---
title: "Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290956992.md"
description: "A biotechnology company, Avalo Therapeutics, Inc. (Nasdaq: AVTX), headquartered in Wayne, Pennsylvania, specializing in therapeutics for immune-mediated inflammatory diseases, revealed that it is set to join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index. This change will come into effect after the closure of U.S. stock markets on June 26, 2026."
datetime: "2026-06-26T11:01:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290956992.md)
  - [en](https://longbridge.com/en/news/290956992.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290956992.md)
---

# Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

A biotechnology company, Avalo Therapeutics, Inc. (Nasdaq: AVTX), headquartered in Wayne, Pennsylvania, specializing in therapeutics for immune-mediated inflammatory diseases, revealed that it is set to join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index. This change will come into effect after the closure of U.S. stock markets on June 26, 2026.

### Related Stocks

- [AVTX.US](https://longbridge.com/en/quote/AVTX.US.md)

## Related News & Research

- [Avalo Therapeutics CMO Mittie Doyle disposes of common shares worth $20,000](https://longbridge.com/en/news/294253150.md)
- [Kazia Therapeutics Files Provisional Patent Backing New Paxalisib Strategy in High-Risk Early TNBC](https://longbridge.com/en/news/294061781.md)
- [Capricor Therapeutics (NASDAQ:CAPR) Receives Neutral Rating from B. Riley Financial](https://longbridge.com/en/news/293955703.md)
- [Prothena (PRTA) Expected to Announce Quarterly Earnings on Monday](https://longbridge.com/en/news/293914353.md)
- [BridgeBio Pharma (BBIO) to Release Quarterly Earnings on Tuesday](https://longbridge.com/en/news/294069905.md)